文献速递瓣膜外科

二尖瓣手术中双心房与左心房消融 lesion 集的風險与获益

Biatrial or Left Atrial Lesion Set for Ablation During Mitral Surgery: Risks and Benefits.
PubMed 文献 · Ann Thorac Surg · 2016-12-22

本研究对比二尖瓣手术患者双心房(BA)与仅左心房(LA)消融的临床结局。2004至2014年单中心724例术前房颤接受消融者中,257例BA、359例LA,经倾向评分匹配后,两组无抗心律失常药物下免于房颤、卒中及生存相似;LA组术后免于再消融更高,永久起搏器植入无差异。结论提示限制于LA消融是BA的有效替代。

要点

  • 二尖瓣手术合并房颤消融,BA与LA组总体结局、生存和并发症相似。
  • 匹配后LA组术后免于再消融更高,但免于房颤无差异。
  • 限制消融 lesion 于左心房可作为双心房消融的有效替代。

核心结论

  • 二尖瓣手术患者接受LA或BA消融的结局、生存和并发症相似,限制于LA消融是BA消融的有效替代。

研究设计与样本

  • 单中心回顾性研究,2004至2014年2,137例二尖瓣手术患者中836例术前房颤,724例接受消融(257例BA、359例LA),并进行倾向评分匹配。

主要发现

  • 基线差异包括BA组术后并发症更多,特别是永久起搏器植入(13% vs 7%;p=0.006)。
  • 无抗心律失常药物下免于房颤(72% BA vs 75% LA;p=0.50)、术后再消融(7% BA vs 5% LA;p=0.20)、卒中(0.11 vs 0.11/10人年;p=0.91)及生存两组相似。
  • 匹配后LA组术后免于再消融更高(p=0.015),但无抗心律失常药物下免于房颤无差异(79% BA vs 69% LA;p=0.09),永久起搏器植入无差异(10% vs 12%;p=0.57)。

关键数值与推荐

  • BA组永久起搏器植入13% vs LA组7%(p=0.006)。
  • 匹配后无抗心律失常药物下免于房颤79% BA vs 69% LA(p=0.09)。
  • 匹配后永久起搏器植入10% BA vs 12% LA(p=0.57)。
  • 卒中发生率0.11 vs 0.11/10人年(p=0.91)。

临床怎么用

  • 二尖瓣手术合并房颤消融时,可考虑将消融 lesion 限制于左心房以替代双心房消融。

局限性

  • 单中心回顾性研究,可能存在选择偏倚,需倾向评分匹配部分校正。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Controversy exists when performing surgical atrial fibrillation ablation whether there is an increase in postoperative complications using biatrial (BA) lesions compared with only left atrial (LA) lesions, and some studies indicate similar efficacy. This study compares the clinical outcomes of BA and LA ablation lesions in mitral valve surgery patients. METHODS: From 2004 through 2014, 2,137 patients had mitral valve surgery with or without other surgeries in a single center. Of those, 836 (39%) had preoperative atrial fibrillation, and of those, 724 (86%) underwent atrial fibrillation ablation surgery; 257 patients had BA lesion sets and 359 had LA lesion sets. Propensity score matching of BA and LA patients was performed. RESULTS: Baseline differences included more postoperative complications in the BA group, specifically, permanent pacemaker placement (13% versus 7%; p = 0.006). Freedom from atrial fibrillation off antiarrhythmic drugs (72% BA versus 75% LA; p = 0.50), postoperative ablation (7% BA versus 5% LA; p = 0.20), stroke (0.11 versus 0.11 per 10 person-years; p = 0.91), and survival were similar between the groups. After matching, patients in the LA group had a higher freedom from postoperative ablation (p = 0.015), but no difference in freedom from atrial fibrillation off antiarrhythmic drugs (79% BA versus 69% LA; p = 0.09), and no difference in permanent pacemaker placement (10% versus 12%; p = 0.57). CONCLUSIONS: Patients undergoing mitral surgery with LA or BA ablation had similar outcomes, survival, and complications. Limiting lesions to the LA is an effective alternative to BA ablation for patients undergoing ablation with concomitant mitral valve surgery.

来源:Ann Thorac Surg,查看原文。版权归原作者所有。

引用

  1. Churyla A, Iddriss A, Andrei AC, et al. Biatrial or Left Atrial Lesion Set for Ablation During Mitral Surgery: Risks and Benefits. Ann Thorac Surg. 2016. PMID: 28017337. doi:10.1016/j.athoracsur.2016.10.017

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。